The findings suggested that the elevated expression levels of m6A regulators, such as CBLL1, METTL14, YTHDC1-2, YTHDF2-3 and ZC3H13, were significantly associated with favorable prognosis of ccRCC, which showed relatively converse clinical implications in patients with other cancers, such as ACC, LGG, LIHC, LUAD, SARC, etcetera (Figure 2E). The gene discussed is CBLL1; the disease is cancer.